| Authors: |
Soskic B; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Cano-Gamez K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Smyth DJ; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Ambridge K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Ke Z; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Matte JC; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Bossini-Castillo L; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Kaplanis J; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Open Targets, Wellcome Genome Campus, Cambridge, UK., Ramirez-Navarro L; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Lorenc A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Nakic N; GSK, R&D, Stevenage, UK., Esparza-Gordillo J; GSK, R&D, Stevenage, UK., Rowan W; GSK, R&D, Stevenage, UK., Wille D; GSK, R&D, Stevenage, UK., Tough DF; GSK, R&D, Stevenage, UK., Bronson PG; R&D Translational Biology, Biogen, Cambridge, MA, USA., Trynka G; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. gosia@sanger.ac.uk.; Open Targets, Wellcome Genome Campus, Cambridge, UK. gosia@sanger.ac.uk. |